These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18776920)

  • 1. Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma.
    Ohtani Y; Harada T; Funasaka Y; Nakao K; Takahara C; Abdel-Daim M; Sakai N; Saito N; Nishigori C; Aiba A
    Oncogene; 2008 Dec; 27(57):7162-70. PubMed ID: 18776920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of metabotropic glutamate receptor subtype 1 and in vivo malignant melanoma formation.
    Abdel-Daim M; Funasaka Y; Komoto M; Nakagawa Y; Yanagita E; Nishigori C
    J Dermatol; 2010 Jul; 37(7):635-46. PubMed ID: 20629830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly pigmented Tg(Grm1) mouse melanoma develops non-pigmented melanoma cells in distant metastases.
    Schiffner S; Chen S; Becker JC; Bosserhoff AK
    Exp Dermatol; 2012 Oct; 21(10):786-8. PubMed ID: 22882420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia.
    Pollock PM; Cohen-Solal K; Sood R; Namkoong J; Martino JJ; Koganti A; Zhu H; Robbins C; Makalowska I; Shin SS; Marin Y; Roberts KG; Yudt LM; Chen A; Cheng J; Incao A; Pinkett HW; Graham CL; Dunn K; Crespo-Carbone SM; Mackason KR; Ryan KB; Sinsimer D; Goydos J; Reuhl KR; Eckhaus M; Meltzer PS; Pavan WJ; Trent JM; Chen S
    Nat Genet; 2003 May; 34(1):108-12. PubMed ID: 12704387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon.
    Marín YE; Namkoong J; Cohen-Solal K; Shin SS; Martino JJ; Oka M; Chen S
    Cell Signal; 2006 Aug; 18(8):1279-86. PubMed ID: 16305822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grm5 expression is not required for the oncogenic role of Grm1 in melanocytes.
    Marín YE; Namkoong J; Shin SS; Raines J; Degenhardt K; White E; Chen S
    Neuropharmacology; 2005; 49 Suppl 1():70-9. PubMed ID: 16040064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamatergic signaling in cellular transformation.
    Teh JL; Chen S
    Pigment Cell Melanoma Res; 2012 May; 25(3):331-42. PubMed ID: 22273393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamate receptor subtype-1 is essential for motor coordination in the adult cerebellum.
    Nakao H; Nakao K; Kano M; Aiba A
    Neurosci Res; 2007 Apr; 57(4):538-43. PubMed ID: 17270300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tg(Grm1) transgenic mice: a murine model that mimics spontaneous uveal melanoma in humans?
    Schiffner S; Braunger BM; de Jel MM; Coupland SE; Tamm ER; Bosserhoff AK
    Exp Eye Res; 2014 Oct; 127():59-68. PubMed ID: 25051141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mouse model for de novo Melanoma.
    Kumasaka MY; Yajima I; Hossain K; Iida M; Tsuzuki T; Ohno T; Takahashi M; Yanagisawa M; Kato M
    Cancer Res; 2010 Jan; 70(1):24-9. PubMed ID: 20048069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.
    Tanami H; Imoto I; Hirasawa A; Yuki Y; Sonoda I; Inoue J; Yasui K; Misawa-Furihata A; Kawakami Y; Inazawa J
    Oncogene; 2004 Nov; 23(54):8796-804. PubMed ID: 15467732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma.
    Laurette P; Coassolo S; Davidson G; Michel I; Gambi G; Yao W; Sohier P; Li M; Mengus G; Larue L; Davidson I
    Cell Death Differ; 2020 Jan; 27(1):29-43. PubMed ID: 31065107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional effects of GRM1 suppression in human melanoma cells.
    Wangari-Talbot J; Wall BA; Goydos JS; Chen S
    Mol Cancer Res; 2012 Nov; 10(11):1440-50. PubMed ID: 22798429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways.
    Jhappan C; Takayama H; Dickson RB; Merlino G
    Cell Growth Differ; 1994 Apr; 5(4):385-94. PubMed ID: 8043512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of metabotropic glutamate receptor 1 dimers requires glutamate binding in both subunits.
    Kammermeier PJ; Yun J
    J Pharmacol Exp Ther; 2005 Feb; 312(2):502-8. PubMed ID: 15466247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine suppresses fibulin-5 and insulin-like growth factor-II receptor expression in melanoma.
    Pos Z; Wiener Z; Pocza P; Racz M; Toth S; Darvas Z; Molnar V; Hegyesi H; Falus A
    Cancer Res; 2008 Mar; 68(6):1997-2005. PubMed ID: 18339882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma.
    Lee DA; Cohen JA; Twaddell WS; Palacios G; Gill M; Levit E; Halperin AJ; Mones J; Busam KJ; Silvers DN; Celebi JT
    Cancer; 2006 Feb; 106(4):907-13. PubMed ID: 16421887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mouse model for skin malignant melanoma.
    Kato M; Takahashi M; Akhand AA; Liu W; Dai Y; Shimizu S; Iwamoto T; Suzuki H; Nakashima I
    Oncogene; 1998 Oct; 17(14):1885-8. PubMed ID: 9778055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice.
    Tormo D; Ferrer A; Bosch P; Gaffal E; Basner-Tschakarjan E; Wenzel J; Tüting T
    Cancer Res; 2006 May; 66(10):5427-35. PubMed ID: 16707471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
    Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.